Full Press Release Details
NEW BRUNSWICK, N.J. , Jan. 17, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) issued the following statement regarding today's Inter Partes Reviews regarding ZYTIGA ® (abiraterone acetate):
About Johnson & Johnson Caring for the world, one person at a time, inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 134,100 employees at more than 250 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.